<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>aaspjournal</PublisherName>
<JournalTitle>Journal of Asian Association of Schools of Pharmacy</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 15 Issue 1</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>Jan - Dec 2026</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Pharmacy</ArticleType>
<ArticleTitle>Constituents with dipeptidyl peptidase-IV inhibitory effect from the flower buds of Rosa rugosa</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>5</LastPage>
<AuthorList>
<Author>
<FirstName>Seikou</FirstName>
<LastName>Nakamura*</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Takahiro</FirstName>
<LastName>Matsumoto</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Rie</FirstName>
<LastName>Yasui</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Toshiki</FirstName>
<LastName>Minamide</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Tomoe</FirstName>
<LastName>Ohta</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Souichi Nakashima and Hisashi</FirstName>
<LastName>Matsuda</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI>https://doi.org/10.62100/jaasp.2026.15101</DOI>
<Abstract>Seven hydrolysable tannins, rugosin A (1), rugosin C (2), rugosin A methyl ester (3), casuarictin (4), tellimagrandin II (5), 1,2,3,4,6-penta-O-galloyl-__ampersandsignbeta;-D-glucopyranose (6), and 1,3-di-O-galloyl-4,6-O-hexahydroxydiphenoyl-__ampersandsignbeta;-D-glucopyranose (7) were isolated from the flower buds of Rosa rugosa. Among these constituents, compounds 1, 2, 3, 5, and 7 exhibited inhibitory activity against dipeptidyl peptidase-IV (DPP-IV), with compound 1 showing the most potent effect. Structure__ampersandsignndash;activity relationship study indicated that the presence of a valoneoyl group plays a critical role in the manifestation of activity. This finding offers important insights into the development of novel DPP-IV inhibitors and antidiabetic agents.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>hydrolysable tannin, rugosin A, Rosa rugosa, dipeptidyl peptidase-IV, antidiabetic agent</Keywords>
<URLs>
<Abstract>https://aaspjournal.org/ubijournal-v1copy/journals/abstract.php?article_id=16140&title=Constituents with dipeptidyl peptidase-IV inhibitory effect from the flower buds of Rosa rugosa</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References/>
</References>
</Journal>
</Article>
</ArticleSet>